Do you want to read an article? Please log in or register.
Adjuvant chemotherapy in stage I triple-negative breast cancer: A systematic review and meta-analysis of survival outcomes
Breast Cancer
Related content
RECOMMENDED
Breast Cancer
Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial
★ 1
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
Lancet Oncol
Yuan J, Bi XW, Hua X, Huang H, Cai L, Zhao L, Chen QJ, Chen XX, Wang XL, Lin Y, Zhang AQ, Zhong YY, Xu F, Huang JJ, An X, Shi YX, Wang X, Wang SS, Xue C, Yuan ZY
doi: 10.1016/S1470-2045(25)00545-5
Breast Cancer
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis
Lancet Oncol
Villacampa G, Pascual T, Tarantino P, Cortés J, Perez-García J, Llombart-Cussac A, Conte P, Mancino M, Guarneri V, Dieci MV, Waks AG, Schettini F, Brasó-Maristany F, Griguolo G, de Castro BA, Reboredo C, Antolín S, Bueno-Muiño C, Echavarría I, López-Tarruella S, Massarrah T, Del Monte-Millán M, Martín M, Buckingham W, Parker JS, Vivancos A, Polyak K, Filho OM, Wolff AC, DeMichele A, Tung NM, Perou CM, Paré L, Villagrasa P, Prat A, Tolaney SM
doi: 10.1016/S1470-2045(25)00276-1
Further Publications
LATE-STAGE OUTCOMES AS SURROGATES FOR MORTALITY IN CANCER SCREENING TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Cancer Epidemiol Biomarkers Prev
Rebolj M, Brentnall AR, Geppert J, Kouppa N, Shinkins B, Freeman K, Stinton C, Randell MJ, Johnson S, Smith RA, Sasieni P, Janes SM, Etzioni R, Duffy SW, Taylor-Phillips S
doi: 10.1158/1055-9965.EPI-25-0201
Further Publications
Patient-Reported Outcomes as Prognostic Indicators for Overall Survival in Cancer: A Systematic Review and Meta-Analysis
JAMA Oncol
Huang RS, Chen D, Benour A, Cortez R, Mihalache A, Johnny C, Bezjak A, Olson RA, Raman S
doi: 10.1001/jamaoncol.2025.3153
Gynecologic Cancer
Neoadjuvant chemotherapy followed by interval surgery versus primary debulking surgery in FIGO stage III-IV epithelial ovarian cancer: A systematic review and meta-analysis
Eur J Cancer
Secchi M, Signorelli M, Rulli E, Maruccio M, Di Martino G, Spadaro D, Giudice E, Turinetto M, Landoni F, Restaino S, Vizzielli G, Martinelli F, Lorusso D
doi: 10.1016/j.ejca.2025.116116
Breast Cancer
Comparison of the pathological complete response between immunohistochemistry HER2 (3 + ) and HER2 (2 + )/ISH + Early-stage breast cancer: a systematic review and meta-analysis
Cancer Treat Rev
Yucel KB, Ilhan Y, Almuradova E, Bardakci M, Dinckal C, Ergun Y
doi: 10.1016/j.ctrv.2025.103074
Further Publications
Impact of beta-blockers on prognostic outcomes in solid cancers: a systematic review and meta-analysis
J Natl Cancer Inst
Eraslan S, Ayhan EC, Madsen MT, Sloan EK, Gögenur I, Orhan A
doi: 10.1093/jnci/djag082
Gynecologic Cancer
Survival Association of Intrauterine Manipulator Use During Minimally Invasive Hysterectomy for Endometrial Cancer: A Systematic Review and Meta-analysis
Obstet Gynecol
Nagase Y, Matsuzaki S, Yoshida H, Nagase S, Tanaka Y, Yamaguchi A, Hisa T, Yokoi T, Ueda Y, Kodama M, Mandai M, Klar M, Roman LD, Ramirez PT, Wright JD, Matsuo K
doi: 10.1097/AOG.0000000000006195
Breast Cancer
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial
Int J Cancer
Beierlein M, Häberle L, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, Wolf C, Kolberg HC, Brucker C, Janni W, Dall P, Schneeweiss A, Marme F, Sütterlin MW, Ruebner M, Theuser AK, Hofmann NM, Böhm S, Almstedt K, Kellner S, Gass P, Lück HJ, Hein A, Schmatloch S, Kalder M, Uleer C, Juhasz-Böss I, Hanf V, Jackisch C, Müller V, Rack B, Belleville E, Wallwiener D, Rody A, Rauh C, Bayer CM, Uhrig S, Huebner H, Goossens C, Brucker SY, Hack CC, Fehm TN, Fasching PA
doi: 10.1002/ijc.70037